Jiang Y - Search Results

1

ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis.

Han J, Shi X, Zhang Y, Xu Y, Jiang Y, Zhang C, Feng L, Yang H, Shang D, Sun Z, Su F, Li C, Li X. Han J, et al. Among authors: jiang y. Sci Rep. 2015 Aug 12;5:13044. doi: 10.1038/srep13044. Sci Rep. 2015. PMID: 26267116 Free PMC article.

2

MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs.

Han J, Liu S, Zhang Y, Xu Y, Jiang Y, Zhang C, Li C, Li X. Han J, et al. Among authors: jiang y. Oncotarget. 2016 Aug 23;7(34):55012-55025. doi: 10.18632/oncotarget.10839. Oncotarget. 2016. PMID: 27474169 Free PMC article.

3

Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer.

Han J, Liu S, Jiang Y, Xu C, Zheng B, Jiang M, Yang H, Su F, Li C, Zhang Y. Han J, et al. Among authors: jiang m, jiang y. J Cell Mol Med. 2018 Sep;22(9):4304-4316. doi: 10.1111/jcmm.13720. Epub 2018 Jul 4. J Cell Mol Med. 2018. PMID: 29971923 Free PMC article.

4

Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data.

Liu S, Zheng B, Sheng Y, Kong Q, Jiang Y, Yang Y, Han X, Cheng L, Zhang Y, Han J. Liu S, et al. Among authors: jiang y. Front Genet. 2019 May 15;10:441. doi: 10.3389/fgene.2019.00441. eCollection 2019. Front Genet. 2019. PMID: 31156704 Free PMC article.

5

Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.

Di J, Zheng B, Kong Q, Jiang Y, Liu S, Yang Y, Han X, Sheng Y, Zhang Y, Cheng L, Han J. Di J, et al. Among authors: jiang y. Mol Oncol. 2019 Oct;13(10):2259-2277. doi: 10.1002/1878-0261.12564. Epub 2019 Aug 21. Mol Oncol. 2019. PMID: 31408580 Free PMC article.

6

CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer.

Sheng Y, Jiang Y, Yang Y, Li X, Qiu J, Wu J, Cheng L, Han J. Sheng Y, et al. Among authors: jiang y. Brief Bioinform. 2021 Sep 2;22(5):bbaa413. doi: 10.1093/bib/bbaa413. Brief Bioinform. 2021. PMID: 33423051

7

Identification of Somatic Mutation-Driven Immune Cells by Integrating Genomic and Transcriptome Data.

Jiang Y, Zheng B, Yang Y, Li X, Han J. Jiang Y, et al. Front Cell Dev Biol. 2021 Jul 21;9:715275. doi: 10.3389/fcell.2021.715275. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34368166 Free PMC article.

8

Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer.

Wang Q, Li X, Wang Y, Qiu J, Wu J, He Y, Li J, Kong Q, Han J, Jiang Y. Wang Q, et al. Among authors: jiang y. Front Genet. 2022 Feb 1;12:801240. doi: 10.3389/fgene.2021.801240. eCollection 2021. Front Genet. 2022. PMID: 35178071 Free PMC article.

9

A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy.

Li X, He Y, Wu J, Qiu J, Li J, Wang Q, Jiang Y, Han J. Li X, et al. Among authors: jiang y. Brief Bioinform. 2022 Sep 20;23(5):bbac360. doi: 10.1093/bib/bbac360. Brief Bioinform. 2022. PMID: 36063561

10

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures.

Li J, Qiu J, Han J, Li X, Jiang Y. Li J, et al. Among authors: jiang y. Genes (Basel). 2022 Oct 29;13(11):1976. doi: 10.3390/genes13111976. Genes (Basel). 2022. PMID: 36360212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,227 results

Search Page

Filters